Benefits

PrenatalSAFE®Karyo test identifies 92.6% of chromosomal anomalies prenatally detected and 96.2% of those anomalies observed at birth, achieving a level of detection rate very closed to the traditional fetal karyotyping (96.8%), obtained with invasive pre-natal diagnostic techniques.
View PrenatalSAFE®Karyo Tables Performance (last update: May 2016)